ENDRA LIFE SCIENCES INC (NDRA) Stock Price, Quote, News and Overview
NASDAQ:NDRA - Nasdaq - US29273B5003 - Common Stock - Currency: USD
NDRA Quote, Performance and Key Statistics
NASDAQ:NDRA (2/21/2025, 8:00:01 PM)
4.3297
-0.22 (-4.84%)
The current stock price of NDRA is 4.3297 USD. In the past month the price decreased by -27.48%. In the past year, price decreased by -99.78%.
NDRA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
| ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
| SYK | STRYKER CORP | 31.4 | 145.92B | ||
| MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
| BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
| IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
| DXCM | DEXCOM INC | 53.81 | 34.68B | ||
| RMD | RESMED INC | 26.21 | 34.03B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Related stock screener links
About NDRA
Company Profile
ENDRA Life Sciences Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Ann Arbor, Michigan and currently employs 21 full-time employees. The company went IPO on 2017-06-28. ENDRA Life Sciences Inc. is developing an enhanced ultrasound technology platform - Thermo Acoustic Enhanced Ultrasound (TAEUS), a technology which characterizes tissue similar to a magnetic resonance imaging (MRI). The firm's TAEUS technology uses radio frequency (RF) pulses to stimulate tissues, using a small fraction (less than 1%) of the amount of energy that would be transmitted into the body during an MRI scan. The use of RF energy allows its TAEUS technology to penetrate deep into tissue, enabling the imaging of human anatomy at depths equivalent to those of conventional ultrasound. The RF pulses are absorbed by tissue and converted into ultrasound signals. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor steatotic liver disease (SLD), a chronic liver disease spectrum. The company is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
Company Info
ENDRA LIFE SCIENCES INC
3600 Green Ct Ste 350
Ann Arbor MICHIGAN 48105 US
CEO: Francois Michelon
Employees: 21
Company Website: https://www.endrainc.com/
Investor Relations: http://investors.endrainc.com/
Phone: 17343350468
ENDRA LIFE SCIENCES INC / NDRA FAQ
What is the stock price of ENDRA LIFE SCIENCES INC today?
The current stock price of NDRA is 4.3297 USD. The price decreased by -4.84% in the last trading session.
What is the ticker symbol for ENDRA LIFE SCIENCES INC stock?
The exchange symbol of ENDRA LIFE SCIENCES INC is NDRA and it is listed on the Nasdaq exchange.
On which exchange is NDRA stock listed?
NDRA stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ENDRA LIFE SCIENCES INC stock?
7 analysts have analysed NDRA and the average price target is 76.5 USD. This implies a price increase of 1666.87% is expected in the next year compared to the current price of 4.3297. Check the ENDRA LIFE SCIENCES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ENDRA LIFE SCIENCES INC worth?
ENDRA LIFE SCIENCES INC (NDRA) has a market capitalization of 2.34M USD. This makes NDRA a Nano Cap stock.
How many employees does ENDRA LIFE SCIENCES INC have?
ENDRA LIFE SCIENCES INC (NDRA) currently has 21 employees.
What are the support and resistance levels for ENDRA LIFE SCIENCES INC (NDRA) stock?
ENDRA LIFE SCIENCES INC (NDRA) has a support level at 4.17 and a resistance level at 4.82. Check the full technical report for a detailed analysis of NDRA support and resistance levels.
Should I buy ENDRA LIFE SCIENCES INC (NDRA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NDRA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NDRA, evaluating the profitability, health, valuation and growth aspects
- ENDRA LIFE SCIENCES INC (NDRA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ENDRA LIFE SCIENCES INC (NDRA) Sales and EPS estimates to see what analysts future expectations are.
- ENDRA LIFE SCIENCES INC (NDRA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ENDRA LIFE SCIENCES INC (NDRA) Insider and Institutional Ownership to learn about the owners and their transactions.
- ENDRA LIFE SCIENCES INC (NDRA) Stock Chart to make your own analysis
- ENDRA LIFE SCIENCES INC (NDRA) Latest news and press-releases to stay up to date.
Does ENDRA LIFE SCIENCES INC (NDRA) stock pay dividends?
NDRA does not pay a dividend.
When does ENDRA LIFE SCIENCES INC (NDRA) report earnings?
ENDRA LIFE SCIENCES INC (NDRA) will report earnings on 2025-03-26, after the market close.
What is the Price/Earnings (PE) ratio of ENDRA LIFE SCIENCES INC (NDRA)?
ENDRA LIFE SCIENCES INC (NDRA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-607.04).
What is the Short Interest ratio of ENDRA LIFE SCIENCES INC (NDRA) stock?
The outstanding short interest for ENDRA LIFE SCIENCES INC (NDRA) is 6.15% of its float. Check the ownership tab for more information on the NDRA short interest.
NDRA Technical Analysis
NDRA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to NDRA. NDRA has a great financial health rating, but its profitability evaluates not so good.
NDRA Financial Highlights
Over the last trailing twelve months NDRA reported a non-GAAP Earnings per Share(EPS) of -607.04. The EPS decreased by -346.35% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -105.24% | ||
| ROE | -133.52% | ||
| Debt/Equity | 0 |
NDRA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to NDRA. The Buy consensus is the average rating of analysts ratings from 7 analysts.